
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.

The Patient Health Questionnaire-9 (PHQ-9) is a self-administered diagnostic tool used primarily in clinical settings to assess the presence and severity of depression. Consisting of nine questions, it evaluates symptoms based on the criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM). The questionnaire asks patients to reflect on their mental health experiences over the past two weeks, quantifying symptoms such as lack of interest, feelings of hopelessness, and changes in sleep or appetite. Each question is scored from zero to three, with higher scores indicating more severe depressive symptoms. This score helps clinicians determine the need for treatment or further evaluation.
The PHQ-9 can be utilized effectively by both clinicians and patients. From a clinical perspective, it serves as a systematic method to screen for depression and monitor patient progress over time. To use the tool, patients are asked to complete the questionnaire independently, a process that typically takes less than five minutes. The responses provide valuable insights into the patient's mental state, allowing healthcare providers to make informed decisions about diagnosis and treatment plans. For patients, the questionnaire offers an opportunity to articulate personal experiences and reflect on mental health changes, which can be useful during consultations.
The PHQ-9's design is straightforward yet comprehensive. It incorporates the following elements:
This structured approach helps differentiate between normal fluctuations in mood and clinically significant depression.
Filling out the PHQ-9 involves the following steps:
The PHQ-9 is widely employed by various professionals in the healthcare domain, such as:
Patients, especially those with a history or risk of depression, may also engage with the questionnaire for personal insight and to facilitate discussions with healthcare providers.


The PHQ-9 is available for use without restrictions, as it was developed with support from Pfizer Inc. and does not require permission for reproduction or application in clinical practice. Its use is consistent with U.S. federal guidelines, and it complies with standards of patient privacy and data protection when administered correctly. Clinicians should ensure confidentiality and secure storage of completed questionnaires to adhere to privacy regulations.
Both digital and paper versions of the PHQ-9 are widely used, each offering unique advantages:
Selecting between the formats depends on the practice setting and patient preferences.
The PHQ-9 can be seamlessly integrated with various healthcare software systems, enhancing the efficiency of mental health screening:
This integration streamlines the workflow for healthcare providers while maintaining the accuracy and privacy of patient data.
Consider two case scenarios:
Case 1: A 45-year-old female, recently divorced, completes the PHQ-9 during a routine check-up. Her score indicates moderate depression. Her physician discusses therapy options, potentially including cognitive behavior therapy or medication.
Case 2: A 21-year-old college student presents with high levels of stress and anxiety. The PHQ-9 is administered, and results show mild depressive symptoms. This insight guides the counselor to tailor specific coping strategies and set follow-up appointments.
These examples illustrate the questionnaire's versatility and applicability across different patient demographics.
At DocHub, your data security is our priority. We follow HIPAA, SOC2, GDPR, and other standards, so you can work on your documents with confidence.
by K Kroenke 2001 Cited by 58250 The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the
Feb 25, 2026 Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.Read more
PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. Question 9 is a single screening question on